EP3796781A4 - Bacteriophage compositions and kits and related methods - Google Patents

Bacteriophage compositions and kits and related methods Download PDF

Info

Publication number
EP3796781A4
EP3796781A4 EP19806872.8A EP19806872A EP3796781A4 EP 3796781 A4 EP3796781 A4 EP 3796781A4 EP 19806872 A EP19806872 A EP 19806872A EP 3796781 A4 EP3796781 A4 EP 3796781A4
Authority
EP
European Patent Office
Prior art keywords
kits
related methods
bacteriophage compositions
bacteriophage
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19806872.8A
Other languages
German (de)
French (fr)
Other versions
EP3796781A1 (en
Inventor
Laura BRIDGEWATER
Gongze ZHAO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of EP3796781A1 publication Critical patent/EP3796781A1/en
Publication of EP3796781A4 publication Critical patent/EP3796781A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP19806872.8A 2018-05-23 2019-05-23 Bacteriophage compositions and kits and related methods Pending EP3796781A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862675652P 2018-05-23 2018-05-23
PCT/US2019/033844 WO2019226950A1 (en) 2018-05-23 2019-05-23 Bacteriophage compositions and kits and related methods

Publications (2)

Publication Number Publication Date
EP3796781A1 EP3796781A1 (en) 2021-03-31
EP3796781A4 true EP3796781A4 (en) 2022-04-20

Family

ID=68617217

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19806872.8A Pending EP3796781A4 (en) 2018-05-23 2019-05-23 Bacteriophage compositions and kits and related methods

Country Status (4)

Country Link
EP (1) EP3796781A4 (en)
CN (1) CN112469426A (en)
CA (1) CA3101242A1 (en)
WO (1) WO2019226950A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195159B (en) * 2020-09-29 2022-10-11 深圳市疾病预防控制中心（深圳市卫生检验中心、深圳市预防医学研究所） Bacteriophage and application thereof
US20240016886A1 (en) * 2020-11-18 2024-01-18 The Board Of Trustees Of The Leland Stanford Junior University Use of annexin v to improve the purity, solubility and long-term stability of phage suspensions
WO2022182329A1 (en) * 2021-02-23 2022-09-01 Adaptive Phage Therapeutics, Inc. Phage therapy of gut microbiota dysbiosis, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
CN114292822B (en) * 2021-12-31 2023-07-14 浙江省农业科学院 Coliphage ZJRP5 and application thereof, bactericide and medicament

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019048930A2 (en) * 2017-09-08 2019-03-14 Keio University Bacteriophage for modulating inflammatory bowel disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
US9839657B2 (en) * 2012-10-30 2017-12-12 Deerland Enzymes, Inc. Prebiotic compositions comprising one or more types of bacteriophage
MX369877B (en) * 2013-02-04 2019-11-25 Seres Therapeutics Inc COMPOSITIONS and METHODS.
EP2799063A1 (en) * 2013-04-30 2014-11-05 Ferring B.V. Bacteriophage therapy
WO2016003307A1 (en) * 2014-07-02 2016-01-07 Limited Liability Company "Bphage" Bacteriophage strains, compositions and related methods
CA3051867A1 (en) * 2017-03-14 2018-09-20 Brigham Young University Methods and compositions for treating obesity, inflammation, or metabolic disorders with bacteriophages

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019048930A2 (en) * 2017-09-08 2019-03-14 Keio University Bacteriophage for modulating inflammatory bowel disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOGOKHIA LASHA ET AL: "Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis", CELL HOST & MICROBE, vol. 25, no. 2, 19 February 2019 (2019-02-19), pages 285, XP085602358, ISSN: 1931-3128, DOI: 10.1016/J.CHOM.2019.01.008 *
PARMAR KRUPA M ET AL: "Genomic characterization of key bacteriophages to formulate the potential biocontrol agent to combat enteric pathogenic bacteria", ARCHIVES OF MICROBIOLOGY, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 200, no. 4, 12 January 2018 (2018-01-12), pages 611 - 622, XP036483187, ISSN: 0302-8933, [retrieved on 20180112], DOI: 10.1007/S00203-017-1471-1 *
See also references of WO2019226950A1 *

Also Published As

Publication number Publication date
CA3101242A1 (en) 2019-11-28
CN112469426A (en) 2021-03-09
EP3796781A1 (en) 2021-03-31
WO2019226950A1 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
EP3823673A4 (en) Anti-cd112r compositions and methods
EP3600325A4 (en) Novel compositions and methods
EP3565397A4 (en) Microbial compositions and methods
EP3773718A4 (en) Compositions and methods comprising anti-nrp2 antibodies
EP3565396A4 (en) Microbial compositions and methods
EP3796781A4 (en) Bacteriophage compositions and kits and related methods
EP3716756A4 (en) Compositions, kits and methods for controlling weed of the amaranthus genus
EP3790861A4 (en) Senolytic compositions and uses thereof
EP3568469A4 (en) Hla-dr car-t compositions and methods of making and using the same
EP3844500A4 (en) Rp182 compositions and methods
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3843729A4 (en) Novel compositions and methods
EP3897615A4 (en) Cannabis compositions and methods
EP3808357A4 (en) Composition and uses thereof
EP3706558A4 (en) Compositions and methods for aquaculturing
GB201815402D0 (en) Compositions and methods and uses relating thereto
GB2578519B (en) Compositions and methods and uses relating thereto
EP3615492A4 (en) Cementitious compositions and methods of making and using the same
EP3612230A4 (en) Palbociclib compositions and methods thereof
EP3921335A4 (en) Compositions and methods involving layilin
EP3818245A4 (en) Cement compositions and methods
EP3796846A4 (en) Urine-sampling kit and methods thereof
EP3880177A4 (en) Actuating components and related methods
EP3678636A4 (en) Topical kits and compositions and use thereof
EP3917320A4 (en) Bacterialcidal methods and compositions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220321

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/76 20150101ALI20220315BHEP

Ipc: A61K 35/742 20150101ALI20220315BHEP

Ipc: A61K 35/741 20150101ALI20220315BHEP

Ipc: A61K 35/74 20150101ALI20220315BHEP

Ipc: A61K 9/48 20060101ALI20220315BHEP

Ipc: A61K 9/00 20060101ALI20220315BHEP

Ipc: A01N 63/00 20200101AFI20220315BHEP